A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

BACKGROUND: Thirty-five percent of pancreatic cancer patients have unresectable locally advanced pancreatic cancer (LAPC) at diagnosis. Several studies have evaluated systemic chemotherapy with FOLFIRINOX for patients with LAPC. We report a patient-level meta-analysis of LAPC patients treated with F...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Oncol
Autors principals: Suker, Mustafa, Beumer, Berend R., Sadot, Eran, Marthey, Lysiane, Faris, Jason E., Mellon, Eric A., El-Rayes, Bassel, Wang-Gillam, Andrea, Lacy, Jill, Hosein, Peter J., Moorcraft, Sing Yu, Conroy, Thierry, Hohla, Florian, Allen, Peter, Taieb, Julien, Hong, Theodore S., Shridhar, Ravi, Chau, Ian, van Eijck, Casper H., Koerkamp, Bas Groot
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527756/
https://ncbi.nlm.nih.gov/pubmed/27160474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)00172-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars